Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2145 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.878 | 49 | 2001 | 2019 | ||||
Malignant neoplasm of breast
|
2154 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.878 | 49 | 2001 | 2019 | ||||
Carcinoma of lung
|
995 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Malignant neoplasm of lung
|
1000 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Non-Small Cell Lung Carcinoma
|
601 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.960 | 25 | 2004 | 2017 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
94 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.960 | 25 | 2004 | 2016 | ||||
Colorectal Carcinoma
|
1186 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.833 | 24 | 2004 | 2016 | ||||
Liver carcinoma
|
769 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.842 | 19 | 2009 | 2020 | ||||
Malignant neoplasm of stomach
|
603 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.750 | 16 | 2002 | 2018 | ||||
Malignant Neoplasms
|
1441 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.813 | 16 | 2003 | 2018 | ||||
Stomach Carcinoma
|
616 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.750 | 16 | 2002 | 2018 | ||||
Glioma
|
283 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.933 | 15 | 2010 | 2017 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.867 | 15 | 2004 | 2015 | ||||
Primary malignant neoplasm
|
1374 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.800 | 15 | 2003 | 2017 | ||||
Carcinoma of bladder
|
290 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.615 | 13 | 2004 | 2016 | ||||
Malignant neoplasm of urinary bladder
|
289 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.615 | 13 | 2004 | 2016 | ||||
Bladder Neoplasm
|
278 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.583 | 12 | 2004 | 2016 | ||||
Cervix carcinoma
|
266 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.833 | 12 | 2005 | 2019 | ||||
Childhood Acute Lymphoblastic Leukemia
|
259 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 1.000 | 10 | 2007 | 2015 | ||||
Malignant neoplasm of prostate
|
861 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.900 | 10 | 2004 | 2018 | ||||
Prostate carcinoma
|
858 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.900 | 10 | 2004 | 2018 | ||||
cervical cancer
|
257 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.090 | 0.778 | 9 | 2005 | 2019 | ||||
Malignant tumor of cervix
|
245 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.090 | 0.778 | 9 | 2005 | 2019 | ||||
Head and Neck Carcinoma
|
118 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.070 | 0.571 | 7 | 2005 | 2014 |